Home
AYTU
AYTU News

Latest Aytu BioPharma Inc. (AYTU) News on June 7, 2025

Aytu BioPharma Third Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

22 days ago

Aytu BioPharma Third Quarter 2025 Earnings: Beats Expectations

Aytu BioPharma Inc (AYTU) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

23 days ago

Aytu BioPharma Inc (AYTU) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...

ACCESS Newswire

24 days ago

Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results

ACCESS Newswire

a month ago

Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025

ACCESS Newswire

2 months ago

Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Loss-Making Aytu BioPharma, Inc. (NASDAQ:AYTU) Set To Breakeven

Simply Wall St.

4 months ago

Loss-Making Aytu BioPharma, Inc. (NASDAQ:AYTU) Set To Breakeven

Aytu BioPharma Inc (AYTU) Q2 2025 Earnings Call Highlights: Strong Cash Position and Strategic ...

GuruFocus.com

4 months ago

Aytu BioPharma Inc (AYTU) Q2 2025 Earnings Call Highlights: Strong Cash Position and Strategic ...

ACCESS Newswire

4 months ago

Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results

ACCESS Newswire

4 months ago

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

ACCESSWIRE

5 months ago

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Aytu BioPharma Proposes Settlement in Shareholder Lawsuit

TipRanks

6 months ago

Aytu BioPharma Proposes Settlement in Shareholder Lawsuit

ACCESSWIRE

6 months ago

Aytu BioPharma Disclosure Notification

ACCESSWIRE

7 months ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

Aytu BioPharma First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

7 months ago

Aytu BioPharma First Quarter 2025 Earnings: Beats Expectations

Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive ...

GuruFocus.com

7 months ago

Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive ...

ACCESSWIRE

7 months ago

Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

ACCESSWIRE

7 months ago

Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024

ACCESSWIRE

8 months ago

Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit

ACCESSWIRE

8 months ago

Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada

Aytu BioPharma Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

8 months ago

Aytu BioPharma Full Year 2024 Earnings: EPS Misses Expectations

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Aytu Biopharma Inc Earnings Call

ACCESSWIRE

8 months ago

Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

ACCESSWIRE

9 months ago

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

Analysts Expect Breakeven For Aytu BioPharma, Inc. (NASDAQ:AYTU) Before Long

Simply Wall St.

9 months ago

Analysts Expect Breakeven For Aytu BioPharma, Inc. (NASDAQ:AYTU) Before Long

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

ACCESSWIRE

10 months ago

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

ACCESSWIRE

10 months ago

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

It's Unlikely That The CEO Of Aytu BioPharma, Inc. (NASDAQ:AYTU) Will See A Huge Pay Rise This Year

Simply Wall St.

a year ago

It's Unlikely That The CEO Of Aytu BioPharma, Inc. (NASDAQ:AYTU) Will See A Huge Pay Rise This Year

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

ACCESSWIRE

a year ago

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

Lytham Partners Spring 2024 Investor Conference Starts Tomorrow, May 30, 2024

Newsfile

a year ago

Lytham Partners Spring 2024 Investor Conference Starts Tomorrow, May 30, 2024

Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

ACCESSWIRE

a year ago

Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

Thomson Reuters StreetEvents

a year ago

Q3 2024 Aytu Biopharma Inc Earnings Call

GuruFocus.com

a year ago

Aytu BioPharma Inc (AYTU) Q3 2024 Earnings Call Transcript Highlights: Strategic Gains Amidst ...

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

ACCESSWIRE

a year ago

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

ACCESSWIRE

a year ago

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

ACCESSWIRE

a year ago

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript

Insider Monkey

a year ago

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript

Aytu BioPharma Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a year ago

Aytu BioPharma Second Quarter 2024 Earnings: Beats Expectations

Thomson Reuters StreetEvents

a year ago

Q2 2024 Aytu Biopharma Inc Earnings Call

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

ACCESSWIRE

a year ago

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

ACCESSWIRE

a year ago

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®

GlobeNewswire

a year ago

LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®

Clene VISIONARY-MS Trial Data May Support CNM-Au8(R) as MS Treatment

NewMediaWire

a year ago

Clene VISIONARY-MS Trial Data May Support CNM-Au8(R) as MS Treatment

SYLA Technologies Enters into a “Capital and Business Alliance Agreement” with RIBERESUTE

GlobeNewswire

a year ago

SYLA Technologies Enters into a “Capital and Business Alliance Agreement” with RIBERESUTE

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

ACCESSWIRE

a year ago

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Bionano Announces Full Commercial Release of the Stratys™ System for High Throughput Optical Genome Mapping

GlobeNewswire

a year ago

Bionano Announces Full Commercial Release of the Stratys™ System for High Throughput Optical Genome Mapping

Reuters

a year ago

GRAPHIC-As price parity beckons, substitution from palladium to platinum to wane

When Will Aytu BioPharma, Inc. (NASDAQ:AYTU) Become Profitable?

Simply Wall St.

a year ago

When Will Aytu BioPharma, Inc. (NASDAQ:AYTU) Become Profitable?

FAT Brands (FAT) Unveils First Co-Branded Los Angeles Location

Zacks

a year ago

FAT Brands (FAT) Unveils First Co-Branded Los Angeles Location

GlobeNewswire

a year ago

Acri Capital Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination

At the 2024 Golden Globes, Diamonds Were Forever

WWD

a year ago

At the 2024 Golden Globes, Diamonds Were Forever

MicroAlgo Inc. Developed QSDLT to Provide a More Secure Foundation for Bitcoin and Other Cryptocurrency Systems

PR Newswire

a year ago

MicroAlgo Inc. Developed QSDLT to Provide a More Secure Foundation for Bitcoin and Other Cryptocurrency Systems

Is it a Good Idea to Sell Sterling Bancorp (SBT) Now?

Insider Monkey

a year ago

Is it a Good Idea to Sell Sterling Bancorp (SBT) Now?

2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street

Motley Fool

a year ago

2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street

G. Willi-Food International Third Quarter 2023 Earnings: EPS: ₪0.35 (vs ₪0.55 in 3Q 2022)

Simply Wall St.

a year ago

G. Willi-Food International Third Quarter 2023 Earnings: EPS: ₪0.35 (vs ₪0.55 in 3Q 2022)

Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors

Business Wire

a year ago

Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors

Business Wire

a year ago

Innovative Solutions & Support, Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Financial Results

Fossil Group (NASDAQ:FOSL) adds US$10m to market cap in the past 7 days, though investors from five years ago are still down 90%

Simply Wall St.

a year ago

Fossil Group (NASDAQ:FOSL) adds US$10m to market cap in the past 7 days, though investors from five years ago are still down 90%

Red Cat Holdings Reports Financial Results for Fiscal Second Quarter 2024 and Provides Corporate Update

GlobeNewswire

a year ago

Red Cat Holdings Reports Financial Results for Fiscal Second Quarter 2024 and Provides Corporate Update

Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal

GlobeNewswire

a year ago

Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal

Business Wire

a year ago

Innovative Solutions & Support, Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Earnings Conference Call

Hyliion Holdings Corp. (NYSE: HYLN) to Host Tech Fireside Chat Showcasing KARNO Linear Generator Technology on December 12th

Business Wire

2 years ago

Hyliion Holdings Corp. (NYSE: HYLN) to Host Tech Fireside Chat Showcasing KARNO Linear Generator Technology on December 12th

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now

GlobeNewswire

2 years ago

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now

Declining Stock and Solid Fundamentals: Is The Market Wrong About Innovative Solutions and Support, Inc. (NASDAQ:ISSC)?

Simply Wall St.

2 years ago

Declining Stock and Solid Fundamentals: Is The Market Wrong About Innovative Solutions and Support, Inc. (NASDAQ:ISSC)?

Envoy Medical to Host Fireside Chat Event December 7

GlobeNewswire

2 years ago

Envoy Medical to Host Fireside Chat Event December 7

Noodles & Company (NASDAQ:NDLS) has caught the attention of institutional investors who hold a sizeable 44% stake

Simply Wall St.

2 years ago

Noodles & Company (NASDAQ:NDLS) has caught the attention of institutional investors who hold a sizeable 44% stake

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

ACCESSWIRE

2 years ago

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 years ago

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode

Business Wire

2 years ago

Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2024 Earnings Call Transcript

Insider Monkey

2 years ago

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2024 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

ACCESSWIRE

2 years ago

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Celcuity Inc Earnings Call

Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire

2 years ago

Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

GuruFocus.com

2 years ago

Celcuity Inc (CELC) Reports Q3 2023 Financial Results and Strategic Developments

Sypris Wins Award for Cryptographic Program

Business Wire

2 years ago

Sypris Wins Award for Cryptographic Program

Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

GlobeNewswire

2 years ago

Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

ACCESSWIRE

2 years ago

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

GlobeNewswire

2 years ago

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023

ACCESSWIRE

2 years ago

Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023

Actinium Presents Preclinical Data at SITC Demonstrating Actimab-A's Potential to Restore T Cell Immunity in the Solid Tumor Microenvironment Supporting Immunotherapy Combinations

PR Newswire

2 years ago

Actinium Presents Preclinical Data at SITC Demonstrating Actimab-A's Potential to Restore T Cell Immunity in the Solid Tumor Microenvironment Supporting Immunotherapy Combinations

Share on Social Networks: